Milestone Pharmaceuticals (MIST) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Quantum Cyber N.V. (QUCY) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 48.7% versus a loss of 84.5%. Over five years, MIST leads with a -93.8% price change compared with -94.8% for QUCY. Milestone Pharmaceuticals is the larger company by market cap ($46.2 million vs $44.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MIST | QUCY |
|---|---|---|
| Share price | $0.3711 | $0.512 |
| Market cap | $46.20M | $44.67M |
| 1-day change | -7.06% | -7.25% |
| YTD return | -81.63% | -54.29% |
| 1-year return | -84.54% | -48.75% |
| 5-year return | -93.85% | -94.80% |
| EPS (TTM) | $-0.74 | $-2.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $537.08K |
| Revenue growth (YoY) | — | -39.92% |
| Net income (latest FY) | $-63.06M | $-16.21M |
| Gross margin | — | 72.58% |
| Operating margin | — | -3004.97% |
| Net margin | — | -3018.31% |
| 52-week high | $3.06 | $4.93 |
| 52-week low | $0.362 | $0.30 |
| Distance from 52-week high | -87.87% | -89.61% |
| Analyst consensus | none | none |
| Avg. price target upside | +1479.09% | +1657.81% |
| Average volume | 1.53M | 528.02K |
| Shares outstanding | 124.50M | 87.24M |
| Employees | 38 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QUCY has outperformed MIST by 35.8 percentage points over the past year.
About Milestone Pharmaceuticals
MIST stock →Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.
Health Care · Biotechnology: Pharmaceutical Preparations · 38 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
MIST vs QUCY FAQ
Which is bigger, Milestone Pharmaceuticals or Quantum Cyber N.V.?
Milestone Pharmaceuticals (MIST) is larger, with a market capitalization of $46.20M compared with $44.67M for Quantum Cyber N.V. (QUCY).
Which stock has performed better over the past year, MIST or QUCY?
QUCY returned -48.75% over the past 12 months, compared with -84.54% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Pharmaceuticals and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.